Abstract Triple‐negative breast cancer (TNBC) is the most aggressive subtype, which often results in distant metastasis and dismal prognosis. Unfortunately, current treatments for TNBC are not effective due to its resistance immunotherapy. Recent studies indicate that B7‐H4 immune checkpoint overexpression inflammation‐initiated neutrophil extracellular traps (NETs) closely associated with poor...